BBCR’s boutique consulting team specializes in rare diseases and orphan indications and dedicated to supporting pharmaceutical innovators, and nurturing each product’s strengths.
- The BBCR team provides consultancy in cell, biologics, and gene therapies
- BBCR addresses sponsors’ questions in the ever-changing regulatory environment
- Clinical strategy for orphan diseases and precision medicine
- RWE can be used to build orphan diseases evidence to support regulatory decisions
- BBCR serves small and medium sized biotech companies,venture capitalists and investors
Specializing in rare disease, Boston Biotech Clinical Research works with biotech, pharmaceutical, device companies and investors to streamline the clinical trial process. Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements.